3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
14
Squamous Cell Carcinoma of Head and Neck
13
Neoplasms
6
Lung Neoplasms
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Neoplasm Metastasis
5
Head and Neck Neoplasms
5
Mouth Neoplasms
4
Carcinoma
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Carcinoma, Squamous Cell
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibromatosis 1
1
Neoplasms by Site
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoid Interstitial Pneumonia
1
Locally Recurrent Skin Squamous Cell Carcinoma
1
Interventions
pembrolizumab
11
enfortumab vedotin
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nivolumab
6
Ipilimumab
4
sacituzumab govitecan
3
Gemcitabine
3
Docetaxel
3
CTLA-4 Antigen
3
zanidatamab
2
cabozantinib
2
atezolizumab
2
Taxes
2
Paclitaxel
2
Cisplatin
2
relatlimab
1
eribulin
1
avelumab
1
X-Rays
1
Single Person
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Platinum
1
Mitomycin
1
Injections
1
Fluorouracil
1
Cystectomy
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Cetuximab
×
30 days
×
Clear all
No trials found.